Home
 /
Papers
 /
Physiology
 /
Mitochondrial membrane junction-mediated ATP channeling drives activity-dependent glucose metabolism
Preprint
Open access
V1
Top 1% · Validated by QED

Mitochondrial membrane junction-mediated ATP channeling drives activity-dependent glucose metabolism

Dengbao Yang, Gemma Molinaro, Nadine Nijem +15 more
December 2025
 ·
bioRxiv
 ·
DOI 
10.64898/2025.12.18.695286
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Physiology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

CEND1 resolves a core metabolic paradox: by scaffolding a conduit that delivers mitochondrial ATP directly to hexokinase, this work explains how neurons and brown adipocytes sustain glucose metabolism precisely when cytosolic ATP becomes limiting during peak activity.

QED claims analysis

Summary

CEND1 enables activity-dependent glucose metabolism in neurons and brown adipocytes by assembling a HK1/VDAC1/ANT1 complex at hemifusion-like OMM/IMM junctions that channels mitochondrially-derived ATP directly to hexokinase I, thereby sustaining glucose phosphorylation and ATP production during periods of high energy demand when cytosolic ATP becomes limiting.

See full analysis
Main Claim 1 –

CEND1 cell-autonomously supports brown adipocyte thermogenesis

Main Claim 2 –

CEND1 drives norepinephrine-stimulated glycolysis and ATP in brown adipocytes

Supporting evidence

  • CEND1 knockout reduces adrenergic-stimulated BAT glucose uptake in vivo
Main Claim 3 –

CEND1 is required for activity-dependent neuronal glucose utilization

Supporting evidence

  • CEND1 loss blocks stimulation-induced glycolytic and TCA 13C flux
Main Claim 4 –

CEND1 sustains ATP levels during neuronal stimulation

Supporting evidence

  • CEND1 deficiency reduces neuronal activity and raises seizure threshold

Abstract

Neurons and brown adipocytes rely on rapid ATP production from accelerated glucose metabolism to sustain bursts of activity upon stimulation, a process known as activity-dependent glucose metabolism. The first committed step in this pathway, the hexokinase I (HK1)-catalyzed phosphorylation of glucose, consumes ATP, raising the question of how this reaction can be accelerated when cytosolic ATP becomes limiting during stimulation. We identify Cell Cycle Exit and Neuronal Differentiation protein 1 (CEND1), expressed in both cell types, as a critical regulator of this process. Loss of CEND1 impairs activity-dependent glucose utilization, ATP generation, and stimulation-evoked activity both in vitro and in vivo. Mechanistically, CEND1 assembles a complex with HK1, voltage-dependent anion channel 1 (VDAC1), and adenine nucleotide translocase 1 (ANT1) at hemifusion-like membrane junction between the outer/inner mitochondrial membrane, channeling mitochondrially derived ATP directly to HK1. These findings uncover a previously unrecognized mechanism that sustains activity-dependent glucose metabolism, with broad implications for energy homeostasis in specialized cell types.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?